These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25501501)

  • 21. Phosphorylation of cardiac voltage-gated sodium channel: Potential players with multiple dimensions.
    Iqbal SM; Lemmens-Gruber R
    Acta Physiol (Oxf); 2019 Mar; 225(3):e13210. PubMed ID: 30362642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Channelopathy of voltage-gated sodium channel].
    Li YJ; Ji YH
    Sheng Li Ke Xue Jin Zhan; 1999 Oct; 30(4):297-302. PubMed ID: 12532821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic and functional mapping of cardiac NaV1.5 channel phosphorylation sites.
    Lorenzini M; Burel S; Lesage A; Wagner E; Charrière C; Chevillard PM; Evrard B; Maloney D; Ruff KM; Pappu RV; Wagner S; Nerbonne JM; Silva JR; Townsend RR; Maier LS; Marionneau C
    J Gen Physiol; 2021 Feb; 153(2):. PubMed ID: 33410863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of phosphorylation sites and binding pockets for modulation of Na
    Iqbal SM; Aufy M; Shabbir W; Lemmens-Gruber R
    FEBS J; 2018 Jul; 285(13):2520-2530. PubMed ID: 29734505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Research update on post-translational modification of cardiac sodium channel Nav1.5].
    Shen LS; Yao Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Jun; 49(6):624-628. PubMed ID: 34126732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural basis for inhibition of the cardiac sodium channel by the atypical antiarrhythmic drug ranolazine.
    Lenaeus M; Gamal El-Din TM; Tonggu L; Zheng N; Catterall WA
    Nat Cardiovasc Res; 2023 Jun; 2(6):587-594. PubMed ID: 39185478
    [No Abstract]   [Full Text] [Related]  

  • 27. The tarantula toxin jingzhaotoxin-XI (κ-theraphotoxin-Cj1a) regulates the activation and inactivation of the voltage-gated sodium channel Nav1.5.
    Tang C; Zhou X; Huang Y; Zhang Y; Hu Z; Wang M; Chen P; Liu Z; Liang S
    Toxicon; 2014 Dec; 92():6-13. PubMed ID: 25240294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From GWAS to function: genetic variation in sodium channel gene enhancer influences electrical patterning.
    van den Boogaard M; Barnett P; Christoffels VM
    Trends Cardiovasc Med; 2014 Apr; 24(3):99-104. PubMed ID: 24360055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton modulation of cardiac I Na: a potential arrhythmogenic trigger.
    Jones DK; Ruben PC
    Handb Exp Pharmacol; 2014; 221():169-81. PubMed ID: 24737236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Desmoplakin expression silencing affects cardiac voltage-gated sodium channel Nav1.5 in HL-1 cells].
    Zhang Q; Deng C; Rao F; Liu X; Mai L; Zhu J; Tan H; Wu S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):983-9. PubMed ID: 23895837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiological and trafficking defects of the SCN5A T353I mutation in Brugada syndrome are rescued by alpha-allocryptopine.
    Zhang J; Chen Y; Yang J; Xu B; Wen Y; Xiang G; Wei G; Zhu C; Xing Y; Li Y
    Eur J Pharmacol; 2015 Jan; 746():333-43. PubMed ID: 25261036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NaV1.5 Na⁺ channels allosterically regulate the NHE-1 exchanger and promote the activity of breast cancer cell invadopodia.
    Brisson L; Driffort V; Benoist L; Poet M; Counillon L; Antelmi E; Rubino R; Besson P; Labbal F; Chevalier S; Reshkin SJ; Gore J; Roger S
    J Cell Sci; 2013 Nov; 126(Pt 21):4835-42. PubMed ID: 23902689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SCN5A splicing variants and the possibility of predicting heart failure-associated arrhythmia.
    Gao G; Dudley SC
    Expert Rev Cardiovasc Ther; 2013 Feb; 11(2):117-9. PubMed ID: 23405830
    [No Abstract]   [Full Text] [Related]  

  • 34. Reversible lysine acetylation: Another layer of post-translational regulation of the cardiac sodium channel.
    Yoon JY; Vikram A; London B; Irani K
    Channels (Austin); 2017 Sep; 11(5):360-361. PubMed ID: 28598266
    [No Abstract]   [Full Text] [Related]  

  • 35. Silencing of desmoplakin decreases connexin43/Nav1.5 expression and sodium current in HL‑1 cardiomyocytes.
    Zhang Q; Deng C; Rao F; Modi RM; Zhu J; Liu X; Mai L; Tan H; Yu X; Lin Q; Xiao D; Kuang S; Wu S
    Mol Med Rep; 2013 Sep; 8(3):780-6. PubMed ID: 23877755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A transgenic zebrafish model of a human cardiac sodium channel mutation exhibits bradycardia, conduction-system abnormalities and early death.
    Huttner IG; Trivedi G; Jacoby A; Mann SA; Vandenberg JI; Fatkin D
    J Mol Cell Cardiol; 2013 Aug; 61():123-32. PubMed ID: 23791817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modelling of an autonomous Nav1.5 channel system as a part of in silico pharmacology study.
    Rayevsky A; Samofalova DO; Maximyuk O; Platonov M; Hurmach V; Ryabukhin S; Volochnyuk D
    J Mol Model; 2021 May; 27(6):182. PubMed ID: 34031769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Say Cheese: Structure of the Cardiac Electrical Engine Is Captured.
    Ghovanloo MR; Ruben PC
    Trends Biochem Sci; 2020 May; 45(5):369-371. PubMed ID: 32311330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of "non-cardiac" voltage-gated sodium channels in cardiac cells.
    Rougier JS; Abriel H
    J Mol Cell Cardiol; 2012 Nov; 53(5):589-90. PubMed ID: 22967322
    [No Abstract]   [Full Text] [Related]  

  • 40. The conformational cycle of a prototypical voltage-gated sodium channel.
    Catterall WA; Wisedchaisri G; Zheng N
    Nat Chem Biol; 2020 Dec; 16(12):1314-1320. PubMed ID: 33199904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.